Search research articles
Contact Us
Filters
Showing results (61-70 of 253) with videos related to
Page
of 26
Sort By:
Journal of Diabetes and Its Complications
|
August 18, 2015
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, et al.
JCEM Case Reports
|
September 29, 2025
Improvement of Symptoms in a Patient With Glycogen Storage Disease Through Nutritional Guidance and Exercise Therapy
Takaaki Morita, Takaaki Murakami, Emi Okamura, et al.
Journal of Dietary Supplements
|
June 4, 2013
Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity
Akira Kobayakawa, Tomoo Suzuki, Takao Ikami, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 24, 2022
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
Munehide Matsuhisa, Hideaki Miyoshi, Daisuke Yabe, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 22, 2023
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
Hideaki Miyoshi, Munehide Matsuhisa, Daisuke Yabe, et al.
Journal of Diabetes Investigation
|
February 17, 2022
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index
Daisuke Yabe, Yuichiro Yamada, Kohei Kaku, et al.
Journal of Diabetes Investigation
|
March 25, 2015
Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
Yukiko Onishi, Elisabeth Niemoeller, Yukio Ikeda, et al.
International Journal of Molecular Sciences
|
November 14, 2023
Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients
Jaeyong Cho, Yukio Horikawa, Yuki Oiwa, et al.
Diabetes, Obesity & Metabolism
|
August 25, 2023
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY)
Daisuke Yabe, Kosuke Shiki, Gosuke Homma, et al.
Expert Opinion on Drug Safety
|
July 26, 2017
Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation
Daisuke Yabe, Yoshiyuki Hamamoto, Yusuke Seino, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 253) with videos related to
Sort By:
Page
of 26
Journal of Diabetes and Its Complications
|
August 18, 2015
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation
Ryota Usui, Daisuke Yabe, Hitoshi Kuwata, et al.
JCEM Case Reports
|
September 29, 2025
Improvement of Symptoms in a Patient With Glycogen Storage Disease Through Nutritional Guidance and Exercise Therapy
Takaaki Morita, Takaaki Murakami, Emi Okamura, et al.
Journal of Dietary Supplements
|
June 4, 2013
Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity
Akira Kobayakawa, Tomoo Suzuki, Takao Ikami, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 24, 2022
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
Munehide Matsuhisa, Hideaki Miyoshi, Daisuke Yabe, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 22, 2023
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
Hideaki Miyoshi, Munehide Matsuhisa, Daisuke Yabe, et al.
Journal of Diabetes Investigation
|
February 17, 2022
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index
Daisuke Yabe, Yuichiro Yamada, Kohei Kaku, et al.
Journal of Diabetes Investigation
|
March 25, 2015
Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
Yukiko Onishi, Elisabeth Niemoeller, Yukio Ikeda, et al.
International Journal of Molecular Sciences
|
November 14, 2023
Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients
Jaeyong Cho, Yukio Horikawa, Yuki Oiwa, et al.
Diabetes, Obesity & Metabolism
|
August 25, 2023
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY)
Daisuke Yabe, Kosuke Shiki, Gosuke Homma, et al.
Expert Opinion on Drug Safety
|
July 26, 2017
Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluation
Daisuke Yabe, Yoshiyuki Hamamoto, Yusuke Seino, et al.
Page
of 26